BioCentury | Oct 8, 2019
Emerging Company Profile

Flagship unveils Cygnal, a nervy take on cancer, inflammation

...Bioelectronics” ). The pharma has also invested in seven bioelectronics companies via its $50 million Action Potential Venture Capital...
BioCentury | Aug 8, 2016
Product Development

Galvanizing bioelectronics

...models. Slaoui said GSK is "in the final stages of determining a winner." Meanwhile, GSK's Action Potential Venture Capital...
BioCentury | Jan 6, 2014
Company News

GlaxoSmithKline other news

...funding to academic groups working in the field. In August, GSK launched its $50 million Action Potential Venture Capital...
BioCentury | Aug 19, 2013
Finance

Electric with potential

...launching a $50 million strategic fund to invest in young companies developing electroceutical programs. GSK's Action Potential Venture Capital...
BioCentury | Aug 12, 2013
Financial News

SetPoint Medical completes venture financing

...Calif. Business: Inflammation Date completed: 8/8/13 Type: Venture financing Raised: $27 million Investors: Covidien Ventures; Action Potential Venture Capital...
BioCentury | Aug 12, 2013
Financial News

GlaxoSmithKline financial update

...GlaxoSmithKline launched its $50 million Action Potential Venture Capital fund, which will invest in five to seven bioelectronics companies...
BioCentury | Aug 9, 2013
Financial News

SetPoint Medical raises $27M in series C

...and Topspin Partners -- along with new investors Covidien Ventures; Boston Scientific Corp. (NYSE:BSX); and Action Potential Venture Capital...
BioCentury | Aug 9, 2013
Financial News

GSK launches $50M bioelectronics fund

...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) launched its $50 million Action Potential Venture Capital fund, which will invest in five to...
Items per page:
1 - 8 of 8
BioCentury | Oct 8, 2019
Emerging Company Profile

Flagship unveils Cygnal, a nervy take on cancer, inflammation

...Bioelectronics” ). The pharma has also invested in seven bioelectronics companies via its $50 million Action Potential Venture Capital...
BioCentury | Aug 8, 2016
Product Development

Galvanizing bioelectronics

...models. Slaoui said GSK is "in the final stages of determining a winner." Meanwhile, GSK's Action Potential Venture Capital...
BioCentury | Jan 6, 2014
Company News

GlaxoSmithKline other news

...funding to academic groups working in the field. In August, GSK launched its $50 million Action Potential Venture Capital...
BioCentury | Aug 19, 2013
Finance

Electric with potential

...launching a $50 million strategic fund to invest in young companies developing electroceutical programs. GSK's Action Potential Venture Capital...
BioCentury | Aug 12, 2013
Financial News

SetPoint Medical completes venture financing

...Calif. Business: Inflammation Date completed: 8/8/13 Type: Venture financing Raised: $27 million Investors: Covidien Ventures; Action Potential Venture Capital...
BioCentury | Aug 12, 2013
Financial News

GlaxoSmithKline financial update

...GlaxoSmithKline launched its $50 million Action Potential Venture Capital fund, which will invest in five to seven bioelectronics companies...
BioCentury | Aug 9, 2013
Financial News

SetPoint Medical raises $27M in series C

...and Topspin Partners -- along with new investors Covidien Ventures; Boston Scientific Corp. (NYSE:BSX); and Action Potential Venture Capital...
BioCentury | Aug 9, 2013
Financial News

GSK launches $50M bioelectronics fund

...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) launched its $50 million Action Potential Venture Capital fund, which will invest in five to...
Items per page:
1 - 8 of 8